Basepaws

Basepaws is a pet genetics company that is dedicated to creating affordable and user-friendly health tests for pet owners. Founded in 2017 by Anna Skaya, the company is based in Los Angeles, CA. Basepaws specializes in developing early detection health risk tests based on genetic and microbiome data. The company focuses on companion animal health research and boasts the world’s first at-home genetic testing platform for cats. On June 22, 2022, Zoetis Inc. (NYSE:ZTS) announced the completion of its acquisition of Basepaws, with the financial terms undisclosed.

This acquisition is expected to bolster Zoetis' portfolio in the precision animal health space, contributing to the future pipeline of petcare innovations. The CEO of Zoetis, Kristin Peck, highlighted that the addition of Basepaws will enable the provision of more comprehensive ways to proactively manage the health, wellness, and quality of care for animals.

The most recent investment in Basepaws was a Venture Round investment on January 1, 2023, in which the company secured funding from East Los Capital. With its focus on biotechnology and its positioning in the United States, Basepaws continues to play a significant role in advancing pet genetics and healthcare.